HEADER RNA 01-AUG-12 2LWK TITLE SOLUTION STRUCTURE OF SMALL MOLECULE-INFLUENZA RNA COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: RNA (32-MER); COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES KEYWDS DOUBLE HELIX, RNA, STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS KEYWDS 2 CENTER FOR INFECTIOUS DISEASE, SSGCID EXPDTA SOLUTION NMR NUMMDL 16 AUTHOR M.-K.LEE,G.VARANI,B.-S.CHOI,M.PELLECCHIA,SEATTLE STRUCTURAL GENOMICS AUTHOR 2 CENTER FOR INFECTIOUS DISEASE (SSGCID) REVDAT 5 15-MAY-24 2LWK 1 REMARK REVDAT 4 14-JUN-23 2LWK 1 REMARK REVDAT 3 15-OCT-14 2LWK 1 JRNL REVDAT 2 18-SEP-13 2LWK 1 AUTHOR KEYWDS REVDAT 1 29-AUG-12 2LWK 0 JRNL AUTH M.K.LEE,A.BOTTINI,M.KIM,M.F.BARDARO,Z.ZHANG,M.PELLECCHIA, JRNL AUTH 2 B.S.CHOI,G.VARANI JRNL TITL A NOVEL SMALL-MOLECULE BINDS TO THE INFLUENZA A VIRUS RNA JRNL TITL 2 PROMOTER AND INHIBITS VIRAL REPLICATION. JRNL REF CHEM.COMMUN.(CAMB.) V. 50 368 2014 JRNL REFN ISSN 1359-7345 JRNL PMID 24247110 JRNL DOI 10.1039/C3CC46973E REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH REMARK 3 AUTHORS : C.D.SCHWIETERS, J.J.KUSZEWSKI, N.TJANDRA AND REMARK 3 G.M.CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2LWK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-AUG-12. REMARK 100 THE DEPOSITION ID IS D_1000102921. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 283 REMARK 210 PH : 6.0 REMARK 210 IONIC STRENGTH : 50 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM INFLUENZA A VIRUS RNA REMARK 210 PROMOTER, 90% H2O, 10% D2O; 1 MM REMARK 210 INFLUENZA A VIRUS RNA PROMOTER, REMARK 210 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : H2O NOESY; D2O NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ; 750 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 16 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 H61 A A 9 H41 C A 25 1.25 REMARK 500 H41 C A 10 O6 G A 24 1.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 10 C A 18 C4' C A 18 C3' -0.067 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0EC A 101 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 18633 RELATED DB: BMRB DBREF 2LWK A 1 32 PDB 2LWK 2LWK 1 32 SEQRES 1 A 32 G A G U A G A A A C A A G SEQRES 2 A 32 G C U U C G G C C U G C U SEQRES 3 A 32 U U U G C U HET 0EC A 101 40 HETNAM 0EC 6,7-DIMETHOXY-2-(PIPERAZIN-1-YL)QUINAZOLIN-4-AMINE FORMUL 2 0EC C14 H19 N5 O2 SITE 1 AC1 8 A A 9 C A 10 A A 11 A A 12 SITE 2 AC1 8 G A 13 C A 22 U A 23 G A 24 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1